HIV/ AIS is one of the most feared infections worldwide and people take it as a death warrant. Many people contract this deadly virus by engaging in the act with HIV-positive people. Sadly, others are born HIV-positive by inheriting the virus from their parents. To live longer and slow down the virus, HIV-positive people have to keep on taking ARVs every day.
Photo courtesy, the image of the HIV vaccine. image used for illustration purposes only.
The good news is that a vaccine has been found that will be administered to HIV-positive people only twice a year. This means that they will no longer have to take ARVs every day as before. This vaccine has been invented by the American food and drug administration which was researching the best ways of curing HIV/AIDS
Photo courtesy, image used for evidence purposes only.
Please share your thoughts on this vaccine in the comments section below. Please do like, comment and share.
Content created and supplied by: LiveUpdates (via Opera
News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform
See More
COMMENTS